Pathology as a scientific and clinical discipline has had increasing relevance in biotechnology and the pharmaceutical industry but is a career track that is often not considered or transparent to pathology trainees and early investigators. This panel discussion shines a light on this topic by providing real life examples of how pathology is being applied in industry and how careers are developed there. Panelists representing a variety of different industry settings and roles will each briefly present how pathology is applied in their unique work context and how their career track brought them to where they are now. A question and answer session will follow the presentations. This session provides trainees, young scientists, pathologists, and the members of the larger scientific community the opportunity to better understand pathology career opportunities in industry and to network with those already engaged in such careers.
Cary D. Austin, MD, PhD, Senior Principal Pathologist & Biobanking Scientific Lead, Genentech Research Pathology (Session Co-Chair)
Shawn P. O’Neil, DVM, PhD, Senior Director & Global Microscopic Imaging Lead, Pfizer Drug Safety Research & Development (Session Co-Chair)
Reina Fuji, VMD, PhD, Senior Principal Pathologist & Director of Digital Pathology, Genentech Safety Assessment Pathology
Keith Wharton Jr., MD PhD, Vice President, Medical Director, Ultivue, Inc.
Suzana S. Couto, DVM, PhD, Senior Director, Head of Pathology, Genmab Inc.
David A. Eberhard, MD PhD, Senior Medical Director (Oncology), Illumina Inc.
Lauri J. Diehl, DVM, PhD, Dip ACVP, Executive Director, Pathobiology, Gilead Sciences
Kate Hammerman, VMD, PhD, DACVP, Veterinary Pathologist/Associate Research Fellow, Pfizer Drug Safety Research & Development
Susan V. Westmoreland, VMD, Senior Principal Pathologist, Abbvie, Immunology, Pharmacology Research & Development